Gentamicin 120 Ug, Streptomycin 30 Ug Sensi-disc Susceptibility Tests
by Becton Dickinson Microbiology Systems
510(k) K943407
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK943407 | Date27 Oct 1994 | StatusActive |
Recalls
No FDA recalls found in the data synced 6 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Full name
- Gentamicin 120 Ug, Streptomycin 30 Ug Sensi-Disc Suspectibility Tests
- 510(k) Number
- FDA Product Code
- JTN
- Device Class
- Class II
- Regulation
- 21 CFR Part 866.1620
- Advisory Committee
- Microbiology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 21 Sep 2026
This device is a susceptibility test disc containing gentamicin 120 ug and streptomycin 30 ug, used for antimicrobial susceptibility testing in microbiology laboratories. It is designed to determine the sensitivity of microorganisms to these antibiotics via the disc diffusion method.
The device is supplied as a sterile, single-use test disc and is intended for use in clinical laboratory settings. It has received FDA 510(k) clearance under product code JTN and regulation number 866.1620, and is classified as a Class II medical device.
Other devices from Becton Dickinson Microbiology Systems
See all devices from Becton Dickinson Microbiology Systems →
Questions
AI-generated answers, 21 Sep 2026
What antibiotics and concentrations are on this susceptibility test disc?
The disc combines gentamicin at 120 µg and streptomycin at 30 µg. These fixed amounts allow the disc diffusion method to assess whether a microorganism is sensitive, intermediate, or resistant to each agent based on zone‑of‑inhibition measurements.
Is the disc supplied sterile and intended for single use?
Yes, the product is provided as a sterile, single‑use test disc. Sterility ensures no contaminating organisms affect the diffusion results, and single‑use eliminates cross‑contamination between specimens, which is essential for reliable susceptibility data.
In what laboratory setting should this disc be used?
The disc is designed for clinical microbiology laboratories that perform antimicrobial susceptibility testing. It is used with standard agar plates and the disc diffusion technique to evaluate the susceptibility of bacterial isolates to gentamicin and streptomycin.
How is this device classified and what regulatory clearance does it have?
It is classified as a Class II medical device and has received FDA 510(k) clearance (product code JTN, regulation 866.1620). The clearance indicates it is substantially equivalent to a legally marketed predicate device for the same intended use.